Phillip Monk - Concepedia

Author

Phillip Monk

Synairgen (United Kingdom)

Also Known As

Mark J. Main, P Monk, P. Monk, P.D. Monk, Phillip D. Monk, Phillip D Monk, Phillip D. Monk, Phillip Monk

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Synairgen (United Kingdom)University Hospital Southampton NHS Foundation Trust University of Southampton NIHR Southampton Respiratory Biomedical Research Unit Southampton General Hospital

About

Phillip Monk is an author at Synairgen (United Kingdom) specializing in medicine, immunology, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.7K
2	Allergy	3	3	463
3	Engineering	1	1	162
4	Allergy Medicine	1	1	52
5	Biomedical Engineering	1	1	162

Phillip Monk

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Defective epithelial barrier function in asthma Xiao Chang, Sarah M. Puddicombe, Sarah A. Field, Journal of Allergy and Clinical Immunology AsthmaImmunologyPulmonary PharmacologyMedicineCell Signaling	2011	619
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial Phillip Monk, Richard Marsden, Victoria Tear, The Lancet Respiratory Medicine Sars-cov-2 InfectionCovid-19 PandemicImmunologyAntiviral TherapyRespiratory Infection	2020	448
The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial Ratko Djukanović, Tim Harrison, Sebastian L. Johnston, American Journal of Respiratory and Critical Care Medicine	2014	265
Increased sputum and bronchial biopsy IL-13 expression in severe asthma Shironjit Saha, Mike Berry, Deborah Parker, Journal of Allergy and Clinical Immunology InflammationAsthmaClinical ImmunologyCytokineAllergy	2008	255
Inhibition of human interleukin‐13‐induced respiratory and oesophageal inflammation by anti‐human‐interleukin‐13 antibody (CAT‐354) Carine Blanchard, Anil Mishra, H. Saito‐Akei, Clinical & Experimental Allergy	2005	178
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis Mark G. Jones, Orestis G. Andriotis, James Roberts, eLife Tissue EngineeringEngineeringInflammatory Lung DiseaseLung InflammationTissue Stiffness	2018	162
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis Mike Berry, Deborah Parker, Natalie Neale, Journal of Allergy and Clinical Immunology AsthmaInflammationInflammatory Lung DiseaseAllergyLung Inflammation	2004	156
Mast cells express IL‐13R<i>α</i>1: IL‐13 promotes human lung mast cell proliferation and Fc<i>ɛ</i>RI expression Davinder Kaur, Fay Hollins, Lucy Woodman, Allergy	2006	81
Barrier responses of human bronchial epithelial cells to grass pollen exposure Cornelia Blume, Emily J. Swindle, Patrick Dennison, European Respiratory Journal	2012	68
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma E. Suzanne Cohen, Claire Dobson, Helena Käck, mAbs AsthmaAllergy MedicineImmunologyAllergenSevere Asthma Patients	2014	52

Page 1